Member Info for draft

They have a name in mind for the Ceo

The DTA WASN'T recognised in the books as they couldn't be sure if there would be future profits but it's irrelevant because the tax losses are there to be used if there is a rto

Indeed.

undervalued, any RTO gets immediate benefit of deferred tax asset - go check the accounts,

shows confidence in the numbers, and the integrity, Big 4 firm. Not many on AIM with big 4 status - must be something big going on at BOX i reckon

Amazing show of confidence

Big things here Ceo with massive stake and Lonza supplying Kirkstall products

For kidney software market is good This is prize winning software

Soon

I think we will secure the next fund bid

I don't really pay here cuz of my other ones keep me busy But yeah I'm in here Good luck all

Can someone answer my questions, I bought in, sounds good. What will be sales price per tonnage . What's the DCF VALUATION OF THIS PROJECT

an acquisiton is being looked at and if it is Bricklive of which the chairman now owns 100% this will go through the ROOF and then SOME

what is the NPV of the project?

This could easily be 30-40p by the end of the year, maybe even sooner with all the focus on REE

The director here owns, 100%," of Bricklive, a Lego live entertainment business, paa have alluded to doing a rto of a live entertainment business This could be a life changing share in my opinion

If this a brick live takeover I'm now expecting £1 here per share

About TRL, LLC Triangle Research Labs, LLC (TRL) launched in Research Triangle Park, North Carolina in 2011. TRL provides high-quality primary human and animal hepatocytes for use in pre-clinical ADMETox applications. The biotechnology company distributes cryopreserved NoSpin HepaRG™ cells and related media for Biopredic International and recently began distributing Quasi Vivo® Cell Culture Flow Systems for Kirkstall Ltd. TRL's expert staff has decades of experience in the hepatic sciences and a strong commitment to providing high quality products that consistently exceed customer expectations. Known for developing lasting relationships, TRL strives to understand individual research needs, and work mutually towards the common goal of improving the quality of life

http://www.prnewswire.com/news-releases/triangle-research-labs-to-host-quasi-vivo-training-workshop-for-research-scientists-300215063.html

https://www.humanrelevantscience.org/launch-event 4-6pm, 8th February 2017 Terrace Dining Room A, Palace of Westminster, London The UK is a world leader in life science research. Yet many breakthroughs are lost in translation from preclinical animal models to humans. There is now a tremendous opportunity to bridge the translational ‘valley of death’ with human relevant technologies. It is time to focus on the human. WHO WE ARE The Alliance for Human Relevant Science is an inclusive collaboration of like-minded companies, organisations and individuals. Working together, we will accelerate innovation and create positive change. Find out more about our founder members: (click/tap on the names for more information) CN Bio Innovations Cyprotex Dr Hadwen Trust Kirkstall Safer Medicines Trust OUR AIMS Support better science for better health Save lives – human and animal – through improved safety and efficacy testing of medicines and other chemicals Save money through more relevant research JOIN US ON 8TH FEBRUARY TO DISCOVER THE BENEFITS OF MEMBERSHIP, INCLUDING: Improve the productivity of your research by getting access to the latest knowledge Find collaborators and partners to help you take advantage of the commercial opportunities created by the shift away from animal based research Get advance notice of funding and grant opportunities